Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An instance of motor neuron disease that is acquired during the lifetime of the individual.
Biomarker and diagnostic research for acquired motor neuron disease has been reported in the published literature.
No clinical trials have been registered for acquired motor neuron disease.
61 publications have been identified in PubMed for acquired motor neuron disease. Research spans Basic Science / Preclinical (25%), Review / Meta-Analysis (21%), and Epidemiology / Natural History (20%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 15 | 25% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about acquired motor neuron disease
Research summaries
13 |
21% |
Disease patterns and progression | 12 | 20% |
Testing and diagnosis research | 8 | 13% |
Patient case studies | 8 | 13% |
Clinical study results | 4 | 7% |
New treatment approaches | 1 | 2% |
Tang C (2026). [PMID: 41423553](https://pubmed.ncbi.nlm.nih.gov/41423553/). *Eur J Nucl Med Mol Imaging*. [Basic Science / Preclinical]
Marsico P (2026). [PMID: 41347594](https://pubmed.ncbi.nlm.nih.gov/41347594/). *Phys Occup Ther Pediatr*. [Basic Science / Preclinical]
Zhou Y (2026). [PMID: 41619527](https://pubmed.ncbi.nlm.nih.gov/41619527/). *Parkinsonism Relat Disord*. [Diagnostic / Biomarker]
Bektaş H (2026). [PMID: 41468720](https://pubmed.ncbi.nlm.nih.gov/41468720/). *Neuromuscul Disord*. [Case Report / Case Series]
Murakami K (2026). [PMID: 41579929](https://pubmed.ncbi.nlm.nih.gov/41579929/). *Neuroscience*. [Basic Science / Preclinical]
Brusa C (2026). [PMID: 40910950](https://pubmed.ncbi.nlm.nih.gov/40910950/). *Dev Med Child Neurol*. [Basic Science / Preclinical]
Birkbeck MG (2026). [PMID: 41570734](https://pubmed.ncbi.nlm.nih.gov/41570734/). *Neuromuscul Disord*. [Diagnostic / Biomarker]
Ghaderi S (2026). [PMID: 42034127](https://pubmed.ncbi.nlm.nih.gov/42034127/). *Brain Res Bull*. [Epidemiology / Natural History]
Cai ZW (2026). [PMID: 41941997](https://pubmed.ncbi.nlm.nih.gov/41941997/). *Brain Res Bull*. [Gene Therapy / Novel Therapeutics]
Trubshaw M (2026). [PMID: 41349953](https://pubmed.ncbi.nlm.nih.gov/41349953/). *Prog Neurobiol*. [Epidemiology / Natural History]
AI-curated news mentioning acquired motor neuron disease
Updated Sep 18, 2026
A groundbreaking RNA therapy has shown improvement in a patient with a rare motor neuron disease, marking a significant advancement in treatment options. This case highlights the potential of RNA-based therapies in addressing challenging neurological conditions.
A case report highlights a de novo FUS frameshift variant (p.Gly501Valfs*30) associated with tremor and extrapyramidal features in young-onset motor neuron disease. This discovery may provide insights into the genetic underpinnings of this condition.
A new study published in PubMed outlines the nationwide epidemiology of motor neuron diseases in Latvia from 2020 to 2024, detailing incidence, prevalence, and clinical characteristics. This research provides valuable insights into the disease landscape in the region.